In any case, both the decease of sympathetic nerve activity and the increase of parasympathetic nerve activity in the heart with SGLT2 inhibitors indicate that SGLT2 inhibitors have preventive effects on cardiac arrhythmias as well as exacerbation of HF. This evidence concerns the gene SLC5A2 and chronic obstructive pulmonary disease.